期刊文献+

VEGF与Ki-67在NSCLC中的表达及其临床意义 被引量:2

Expression of VEGF and Ki-67 in lung tissues of NSCLC and its clinical significance
下载PDF
导出
摘要 目的:探讨血管内皮生长因子(VEGF)与核增殖抗原(Ki-67)在非小细胞肺癌(NSCLC)中的表达及临床意义。方法:选取150例NSCLC患者为研究对象,分为死亡组(n=38)和存活组(n=112)。分别取每例患者的癌组织及癌旁组织各1份,采用SP法检测VEGF及Ki-67水平。比较死亡组与存活组、癌组织与癌旁组织VEGF及Ki-67阳性表达水平;分析VEGF和Ki-67阳性表达与NSCLC临床病理特征的关系及癌组织VEGF与Ki-67阳性表达的相关性。结果:死亡组患者癌组织VEGF和Ki-67阳性表达率高于存活组(P<0.05);癌组织VEGF和Ki-67阳性表达率高于癌旁组织(P<0.05);相关性分析显示,VEGF阳性表达与肿瘤直径、淋巴结转移、远处转移及临床分期相关(P<0.05),Ki-67阳性表达与淋巴结转移相关(P<0.05);回归分析显示,癌组织VEGF与Ki-67阳性表达呈正相关(P<0.05)。结论:NSCLC患者中,癌组织中VEGF与Ki-67表达水平较高,且与患者临床病理学特征相关,可作为早期诊断及判断预后的重要依据。 Objective:To investigate the expression of Vascular endothelial growth factor(VEGF)and Nuclear proliferative antigen Ki-67 in lung tissue of non-small cell lung cancer(NSCLC)and its clinical significance.Methods:150 patients with NSCLC were divided into death group(n=38)and survival group(n=112).One piece of lung tissue and one piece of paracancerous tissue were taken from each patient,the levels of VEGF and Ki-67 were detected by SP immunohistochemistry.The positive expression levels of VEGF and Ki-67 in death group and survival group,lung tissue and paracancerous tissue were compared.The relationship between the expression of VEGF and Ki-67 and the clinicopathological features of NSCLC and the correlation between the expression of VEGF and Ki-67 were analyzed.Results:The positive expression rates of VEGF and Ki-67 in cancer tissue of death group were significantly higher than those in survival group(P<0.05).The positive expression rates of VEGF and Ki-67 in lung tissue were higher than those in paracancerous tissue(P<0.05).Correlation analysis showed that the positive expression of VEGF was significantly correlated with tumor diameter,lymph node metastasis,distant metastasis and clinical stage in NSCLC patients(P<0.05).The positive expression of Ki-67 was significantly correlated with lymph node metastasis(P<0.05).Regression analysis showed that there was a positive correlation between VEGF and Ki-67(P<0.05).Conclusion:VEGF and Ki-67 are highly expressed in lung tissues of NSCLC,and are related to the clinicopathological characteristics of patients,which can be used as an important basis for early clinical diagnosis and treatment of NSCLC.
作者 李健 王超 贾旺 丁家宝 梁华刚 高鲲 贾瑞 LI Jian;WANG Chao;JIA Wang;DING Jia-bao;LIANG Hua-gang;GAO Kun;JIA Rui(Department of Thoracic Surgery,First Hospital of Qinhuangdao;Department of Anesthesiology,Maternity and Child Care Center of Qinhuangdao,Qinhuangdao 066000,Hebei,China)
出处 《川北医学院学报》 CAS 2021年第6期727-729,共3页 Journal of North Sichuan Medical College
基金 河北省秦皇岛市重点研发计划科技支撑项目(202004A103)。
关键词 非小细胞肺癌 血管内皮生长因子 核增殖抗原 临床病理特征 Non-small cell lung cancer Vascular endothelial growth factor Nuclear proliferation antigen Characteristics of clinical cases
  • 相关文献

参考文献7

二级参考文献44

  • 1宋作庆,徐萧洪,韦森,陈军,周乃康.肝素酶在非小细胞肺癌中的表达及其临床意义[J].中国肺癌杂志,2008,11(6):798-801. 被引量:6
  • 2陈香丽,张王刚,陈小燕,孙忠民,刘苏虎.S100A4蛋白在非小细胞肺癌中的表达与侵袭和转移的关系[J].癌症,2006,25(9):1134-1137. 被引量:18
  • 3Travis WD. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas [J]. Mod Pathol, 2012, 25Suppl 1: $18-$30.
  • 4Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? [ J ]. Cancer,2015,121 ( 5 ) :664-672.
  • 5Ao MH, Zhang H, Sakowski L, et al. The utility of a novel triple marker (combination of TTF1, napsin A, and p40 ) in the subclassification of non-small cell lung cancer[J] . Hum Pathol, 2014, 45(5) :926-934.
  • 6Hamanaka W, Motoi N, Ishikawa S, et al. A subset of small cell lung cancer with low neuroendocrine expression and good prognosis : a comparison study of surgical and inoperable cases with biopsy [J]. Hum Pathol,2014, 45(5) :1045-1056.
  • 7Tatsumori T, Tsuta K, Masai K, et al. p40 is the best marker for diagnosing pulmonary squamous cell carcinoma: comparison with p63, eytokeratin 5/6, desmocollin-3, and sox2 [ J ]. Appl Immunohistochem Mol Morphol,2014, 22(5 ) :377-382.
  • 8Masai K,Tsuta K, Kawago M, et al. Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas [ J ]. Appl Immunohistochem Mol Morphol,2013, 21 (4) :292-297.
  • 9Au NH, Gown AM, Cheang M, et al. P63 expression in lung carcinoma: a tissue microarray study of 408 cases [ J]. Appl Immunohistochem Mol Morphol,2004, 12 (3) :240-247.
  • 10Zhang C, Schmidt LA, Hatanaka K, et al. Evaluation of napsin A, TI'F-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors [ J ]. Am J Clin Pathol, 2014, 142 (3) :320-324.

共引文献75

同被引文献27

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部